LEXINGTON, Mass. (AP) _ Curis Inc. (CRIS) on Tuesday reported a loss of $15.5 million in its third quarter.
The Lexington, Massachusetts-based company said it had a loss of 11 cents per share.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 9 cents per share.
The drug developer posted revenue of $2.4 million in the period.
The company's shares closed at $1.51. A year ago, they were trading at $2.44.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CRIS at https://www.zacks.com/ap/CRIS